# MOVIPREP® Versus PICOLAX® Pilot Study

> **NCT00312481** · PHASE2 · COMPLETED · sponsor: **Norgine** · enrollment: 65 (actual)

## Conditions studied

- Colonoscopy

## Interventions

- **DRUG:** macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate
- **DRUG:** NA picosulfate magnesium citrate

## Key facts

- **NCT ID:** NCT00312481
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2007-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312481, "MOVIPREP® Versus PICOLAX® Pilot Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00312481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*